Skip to main content

Table 1 Basal characteristics of the total study population and divided into genders

From: Gender difference in adiponectin associated with cardiovascular mortality

Variables Total population Males Females p-value
N 476 242 234  
Age, mean (SD) 77.0 (3.4) 77.0 (3.2) 77.0 (3.7)  
BMI, (SD) 27.2 (4.3) 26.7 (3.3) 27.6 (5.1) 0.02
IHD, n (%) 105 (22.1) 63 (26.0) 42 (17.9) 0.03
Hypertension, n (%) 359 (75.4) 174 (71.9) 185 (79.1) 0.003
ACEI/ARB, n (%) 125 (26.3) 64 (26.4) 61 (26.1) 0.93
Hb < 120 g/L, n (%) 51 (10.7) 16 (6.6) 35 (15.0) 0.003
Beta blockers, n (%) 168 (35.3) 90 (37.2) 78 (33.3) 0.38
b-glucose, mmol/L, mean, (SD) 4.6 (1.3) 4.5 (1.2) 4.6 (1.4) 0.57
HDL, mmol/L mean, (SD) 1.5 (0.4) 1.3 (0.3) 1.6 (0.4) <0.0001
eGFR < 60 mL/min, n (%) 233 (48.9) 116 (47.9) 117 (50.0) 0.65
CRP, mg/L, mean (SD) 11.0 (5.1) 11.0 (5.0) 11.0 (5.3) 0.68
EF < 40 %, n (%) 36 (7.6) 27 (11.2) 9 (3.8) 0.003
NT-proBNP ng/L, mean, (SD) 188 (319) 201 (395) 174 (200) 0.37
Adiponectin pg/mL, mean, (SD) 6263 (4690) 4829 (3391) 7884 (5387) <0.0001
  1. Notes: ACEI/ARB: Angiotensin converting enzyme inhibitor/Angiotensin receptor blocker; BMI: Body mass index; CRP: C-reactive protein; EF: Ejection fraction; eGRF: Estimated glomerular filtration rate; HDL; High density lipoproteins; IHD: Ischemic heart disease; NT-proBNP: N-terminal fragment of proBNP